CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis

Hardiman, 2017, Amyotrophic lateral sclerosis, Nat Rev Dis Prim [Internet], 3, 17071, 10.1038/nrdp.2017.71 Hardiman, 2011, Clinical diagnosis and management of amyotrophic lateral sclerosis, Nat Rev Neurol [Internet], 7, 639, 10.1038/nrneurol.2011.153 Beghi, 2011, The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials, Amyotroph Later Scler [Internet], 12, 1, 10.3109/17482968.2010.502940 Turner, 2013, Mechanisms, models and biomarkers in amyotrophic lateral sclerosis, Amyotroph Later Scler Front Degener [Internet], 14, 19, 10.3109/21678421.2013.778554 Boillée, 2006, ALS: a disease of motor neurons and their nonneuronal neighbors, Neuron [Internet], 52, 39, 10.1016/j.neuron.2006.09.018 Yamanaka, 2008, Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis, Nat Neurosci [Internet], 11, 251, 10.1038/nn2047 Thonhoff, 2018, Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis, Curr Opin Neurol [Internet], 31, 635, 10.1097/WCO.0000000000000599 Beers, 2008, CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS, Proc Natl Acad Sci U S A [Internet], 105, 15558, 10.1073/pnas.0807419105 Chiu, 2008, T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS, Proc Natl Acad Sci U S A [Internet], 105, 17913, 10.1073/pnas.0804610105 Boulanger, 2009, Immune proteins in brain development and synaptic plasticity, Neuron [Internet], 64, 93, 10.1016/j.neuron.2009.09.001 Nardo, 2016, Major histocompatibility complex I expression by motor neurons and its implication in amyotrophic lateral sclerosis, Front Neurol [Internet], 7 Kwon, 2015, CCL2 mediates neuron-macrophage interactions to drive proregenerative macrophage activation following preconditioning injury, J Neurosci [Internet], 35, 15934, 10.1523/JNEUROSCI.1924-15.2015 Charo, 2006, The many roles of chemokines and chemokine receptors in inflammation, N Engl J Med [Internet], 354, 610, 10.1056/NEJMra052723 de Haas, 2007, Neuronal chemokines: versatile messengers in central nervous system cell interaction, Mol Neurobiol [Internet], 36, 137, 10.1007/s12035-007-0036-8 Savarin-Vuaillat, 2007, Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?, Neurotherapeutics [Internet], 4, 590, 10.1016/j.nurt.2007.07.004 Kuhle, 2009, Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis, Eur J Neurol [Internet], 16, 771, 10.1111/j.1468-1331.2009.02560.x Endo, 2016, Neuroinflammation in motor neuron disease, Clin Exp Neuroimmunol [Internet], 7, 126, 10.1111/cen3.12309 de Oliveira, 2013, Early gene expression changes in spinal cord from SOD1G93A amyotrophic lateral sclerosis animal model, Front Cell Neurosci [Internet], 7 Zhang, 2018, Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model, Transl Neurodegener [Internet], 7, 35, 10.1186/s40035-018-0138-4 Ansel, 2000, A chemokine-driven positive feedback loop organizes lymphoid follicles, Nature [Internet], 406, 309, 10.1038/35018581 Förster, 1996, A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen, Cell [Internet], 87, 1037, 10.1016/S0092-8674(00)81798-5 Bagaeva, 2006, CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis, J Immunol [Internet], 176, 7676, 10.4049/jimmunol.176.12.7676 Magliozzi, 2004, Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis, J Neuroimmunol [Internet], 148, 11, 10.1016/j.jneuroim.2003.10.056 Smith, 2003, Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma, Blood [Internet], 101, 815, 10.1182/blood-2002-05-1576 Irani, 2016, Regulated production of CXCL13 within the central nervous system, J Clin Cell Immunol [Internet], 7 Krumbholz, 2006, Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment, Brain [Internet], 129, 200, 10.1093/brain/awh680 Sellebjerg, 2009, Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS, Neurology [Internet], 73, 2003, 10.1212/WNL.0b013e3181c5b457 Fischer, 2009, CXCL13 and CXCL12 in central nervous system lymphoma patients, Clin Cancer Res [Internet], 15, 5968, 10.1158/1078-0432.CCR-09-0108 Jiang, 2016, CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5, J Clin Invest [Internet], 126, 745, 10.1172/JCI81950 Esen, 2014, Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13, Glia [Internet], 62, 1452, 10.1002/glia.22692 Monson, 2014, Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke, J Neuroinflamm [Internet], 11, 22, 10.1186/1742-2094-11-22 Nardo, 2013, Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis, Brain [Internet], 136, 3305, 10.1093/brain/awt250 Brooks, 1994, El escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis, J Neurol Sci [Internet], 124, 96, 10.1016/0022-510X(94)90191-0 Klimatcheva, 2015, CXCL13 antibody for the treatment of autoimmune disorders, BMC Immunol [Internet], 16, 6, 10.1186/s12865-015-0068-1 Nardo, 2018, Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice, Mol Neurodegener [Internet], 13, 42, 10.1186/s13024-018-0271-7 De Paola, 2012, Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration, Mol Med [Internet], 18, 971, 10.2119/molmed.2012.00020 Ludolph, 2010, Guidelines for preclinical animal research in ALS/MND: a consensus meeting, Amyotroph Later Scler [Internet], 11, 38, 10.3109/17482960903545334 Kilkenny, 2010, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol [Internet], 8 Huang, 2017, Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice. Boulton ME, editor, PLoS One [Internet], 12 Banerjee, 2008, Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. McCabe BD, editor, PLoS One [Internet], 3, e2740, 10.1371/journal.pone.0002740 Noguchi, 2017, Pharmacokinetics of an intracerebroventricularly administered antibody in rats, MAbs [Internet], 9, 1210, 10.1080/19420862.2017.1345834 Hussain, 2019, CXCL13/CXCR5 signaling axis in cancer, Life Sci [Internet], 227, 175, 10.1016/j.lfs.2019.04.053 Waite, 2012, Th17 response and inflammatory autoimmune diseases, Int J Inflam [Internet], 2012, 1 Brettschneider, 2013, Stages of pTDP-43 pathology in amyotrophic lateral sclerosis, Ann Neurol [Internet], 74, 20, 10.1002/ana.23937 Marino, 2015, Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis, Neurobiol Aging [Internet], 36, 492, 10.1016/j.neurobiolaging.2014.06.026 Nardo, 2016, New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models, Brain Pathol [Internet], 26, 237, 10.1111/bpa.12351 Ramesh, 2009, Possible role of glial cells in the onset and progression of Lyme neuroborreliosis, J Neuroinflamm [Internet], 6, 23, 10.1186/1742-2094-6-23 Narayan, 2005, The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis, Ann Neurol [Internet], 57, 813, 10.1002/ana.20486 Peviani, 2014, Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis, Mol Neurobiol [Internet], 49, 136, 10.1007/s12035-013-8507-6 Vallarola, 2018, RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue, J Neuroinflamm [Internet], 15, 65, 10.1186/s12974-018-1101-0 Kowarik, 2012, CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation, J Neuroinflamm [Internet], 9, 624 Rupprecht, 2009, The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis, J Neuroinflamm [Internet], 6, 42, 10.1186/1742-2094-6-42 Naor, 2009, Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes, J Neurol [Internet], 256, 1228, 10.1007/s00415-009-5097-3 Rentzos, 2010, Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?, Acta Neurol Scand [Internet], 122, 425, 10.1111/j.1600-0404.2010.01333.x Fiala, 2010, IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients, J Neuroinflammation [Internet], 7, 76, 10.1186/1742-2094-7-76 Boulanger, 2004, Immune signalling in neural development, synaptic plasticity and disease, Nat Rev Neurosci [Internet], 5, 521, 10.1038/nrn1428 Pehar, 2005, Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis, Neurodegen Dis [Internet], 2, 139, 10.1159/000089619 Song, 2016, Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis, Nat Med [Internet], 22, 397, 10.1038/nm.4052 Nardo, 2016, Immune response in peripheral axons delays disease progression in SOD1G93A mice, J Neuroinflamm [Internet], 13, 261, 10.1186/s12974-016-0732-2 Allen, 2004, Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5, Nat Immunol [Internet], 5, 943, 10.1038/ni1100 Lazarini, 2003, Role of the ?-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system, Glia [Internet], 42, 139, 10.1002/glia.10139 Klein, 2004, Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity, Trends Immunol [Internet], 25, 306, 10.1016/j.it.2004.04.002 Stumm, 2002, A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia, J Neurosci [Internet], 22, 5865, 10.1523/JNEUROSCI.22-14-05865.2002 Negro, 2017, <scp>CXCL</scp>12α/ <scp>SDF</scp>‐1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals, EMBO Mol Med [Internet], 9, 1000, 10.15252/emmm.201607257 El Khoury, 2019, Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra, Analyst [Internet], 144, 4647, 10.1039/C9AN00754G Leypoldt, 2015, Investigations on CXCL13 in Anti - N -methyl- D - aspartate receptor encephalitis, JAMA Neurol [Internet], 72, 180, 10.1001/jamaneurol.2014.2956 Kim, 2019, Serum CXCL13 reflects local B-cell mediated inflammatory demyelinating peripheral neuropathy, Sci Rep [Internet], 9, 16535, 10.1038/s41598-019-52643-2 Alvarez, 2013, CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions, Mult Scler J [Internet], 19, 1204, 10.1177/1352458512473362 Nissen, 2019, Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis, Front Neurol [Internet], 10